HENRY SCHEIN INC

Henry Schein (HSIC) will release Q1 2025 earnings on May 5th [2]. Despite a recent market rally boosting the stock price [1], the consensus EPS estimate has decreased, and the stock has a Zacks Rank of #4 (Sell) [1], [8]. Concerns remain about declining organic revenue, low revenue growth projections, and a declining return on invested capital [5], [7]. While the company's commitment to net-zero emissions by 2050 and participation in the 2025 International Dental Show are positive developments [3], [6], downward analyst estimate revisions and underperformance compared to the S&P 500 suggest a bearish short-term outlook [8]. A potential minor tailwind exists from Utah's water fluoridation ban, but its impact remains uncertain [4].